MELISA is an optimised, clinically validated blood test which measures hypersensitivity to multiple metals from a single sample. MELISA can also to help in the diagnosis of active Lyme disease.
Exposure to metals in dental fillings and implants, joint prostheses, pacemakers, environmental pollutants and jewellery can lead to health problems in susceptible individuals.
MELISA improves laboratory diagnosis by confirming active disease in patients with clinical symptoms of Lyme.
The FDA has issued a statement addressing the concerns about the bio-compatibility and function of medical devices. Our conference in November 2018 mirrored these concerns
Download our leaflets on various topics such as metal hypersensitivity in orthopaedics, dentistry, spinal surgery and titanium implants.
On 23 November, a 3-hour session on Hypersensitization Reactions due to Metal and Metalloid Exposure will be broadcast as part of The 2nd International Industrial
The latest newsletter looks at actions taken by the FDA following on from the Medical Devices Committee meeting in November 2019. We also look at
People with known heightened sensitivity (allergy) to mercury or other components of dental amalgam should not get amalgam fillings, according to FDA’s new directives on
Metal Hypersensitivity in Knee Replacement Surgery Webinar recording Consultant Orthopaedic surgeons, Alberto Gregori and David Donaldson discuss the prevalence of hypersensitivity, symptoms post-op and how
The MELISA Summer Newsletter focuses on autoimmune diseases, inflammation and metal hypersensitivity. We cover an uplifting story of a nickel-allergic client who is now feeling
The latest Newsletter is out, the MELISA team are focusing on maintaining a healthy immune system and advice from functional medicine doctors. MELISA Spring Newsletter
The following conference is organised to with the aim to make the healthcare profession aware of the increase in diseases related to metal hypersensitivity and
In November, FDA will discuss the topic of immunological responses to metal-containing products regulated as medical devices. The discussion will focus on metal-containing implants as
On 11-12th October we’ll be presenting “Systemic effects of metal restorations and implants due to hypersensitivity: MELISA testing and case studies” at The International Academy
Our summer newsletter is out with the latest from the FDA about allergy to medical devices, concerns over titanium nanoparticles, LTT testing in failing knee
We offer various services lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt.
“MELISA is a fundamental cornerstone of my practice."
Functional Medicine Based Dentistry, Santa Rosa, CA, USA
“I have many patients that are interested in this type of testing associated with implants. Thank you for the great work you have done.”
Foot & Ankle Center, Wenatchee, WA, USA
“A type IV metal allergy is often overlooked as a culprit in many of today's chronic illnesses. MELISA testing gives targeted information on what needs to be avoided. Many patients get their life back with this information instead of remaining chronically ill for the rest of their days.”
Mount Diablo Integrated Wellness Center, Walnut Creek, CA, USA
“Working in holistic dentistry I use an integrated approach and treat the patient as a whole, focusing on the dental need in the larger context of the person’s overall well-being. MELISA provides me with invaluable information for the most suitable materials to be used.”
The Ella Clinic, London, UK
In this study, patients with medically unexplained physical symptoms - which they attributed to dental amalgam restorations - had their amalgam restorations removed. The outcome was significant reduction of health complaints.
onlinelibrary.wiley.com/doi/10.1111/joor.13080
onlinelibrary.wiley.com
Background The Norwegian Ministry of Health and Care Services initiated a project including experimental treatment for patients with health complaints attributed to amalgam restorations. Objective...Our Autumn newsletter is now out. We look at actions taken by the FDA following on from the Medical Devices Committee meeting in November 2019. We also look at systemic hypersensitivity in a spinal patient and nickel allergy in those with coeliac disease.
mailchi.mp/c5d85e1caae0/melisa-newsletter-autumn-2020
mailchi.mp
Back to some kind of normal! As of November 11th, it is now possible to send for MELISA testing from the US and Canada.In this case report, occupational exposure to mercury caused ALS in a 54-year-old male worker. The authors ague that personalised occupational health practices and searching for genetic biomarkers of susceptibility in those who are regularly exposed to high levels of mercury at work could prevent serious and irreversible consequences of occupational exposure.
www.mdpi.com/2076-3417/10/21/7839/pdf
A silver lining of the current pandemic is that conferences move online and are therefore accessible to anyone. On the 23rd November, there is a session on Hypersensitization Reactions due to Metal and Metalloid Exposure, a part of an international meeting on industrial and environmental toxicology. This session will cover: Introduction to Metal-induced Hypersensitization, Metal-induced Reactions Resulting from Implants and The Link to Autoimmune Disorders as well as Sensitization Tests and Their Availability.
www.ietox2020.com/en/42858/23-November-2020
